Healthpeak Properties stock faces peer exclusion scrutiny as Realty Income reshapes REIT benchmarks for 2026

ISIN: US42250P1030. Healthpeak Properties stock draws attention after exclusion from Realty Income's 2025 peer group in latest proxy filing, signaling shifting competitive dynamics in the healthcare REIT sector amid ongoing portfolio transitions and market realignments.

Healthpeak Properties stock, listed under ISIN US42250P1030, has entered investor focus following its removal from Realty Income Corporation's peer group for 2025 performance benchmarking. This development, detailed in Realty Income's definitive proxy statement filed with the SEC, highlights evolving sector comparisons for REITs, particularly those with healthcare exposures. US investors should monitor this as it underscores potential valuation pressures and strategic repositioning in the real estate investment trust space.

As of: 26.03.2026

Dr. Elena Marquez, Senior REIT Analyst and Healthcare Property Specialist: In a sector where peer group composition directly influences compensation metrics and investor perceptions, Healthpeak Properties' exclusion from key benchmarks signals deeper questions about its post-merger trajectory and competitive standing.

Peer Group Shakeup Triggers Market Reassessment

Realty Income Corporation, a prominent net lease REIT, disclosed in its DEF 14A proxy statement that Healthpeak Properties, alongside Essex Property Trust and W.P. Carey, was removed from its 2025 peer group. The filing specifies reasons for these changes but emphasizes Realty Income's robust 2025 performance, including a 2.9% dividend increase and record AFFO per share of $4.28.

This exclusion comes at a pivotal time for Healthpeak Properties stock. Investors view peer group adjustments as barometers of relative strength, especially in REITs where total shareholder returns and operational metrics drive executive pay and strategic narratives. For Healthpeak, previously known in parts of its history as Doctor's Office Company (DOC), this move amplifies scrutiny on its healthcare-focused portfolio amid broader real estate market shifts.

The proxy details Realty Income's achievements, such as $6.3 billion in investments at a 7.3% initial cash yield and 98.9% occupancy, positioning it as a diversification play contrasting with more specialized healthcare REITs like Healthpeak. US investors tracking NYSE-listed REITs note that such peer realignments can influence ETF inclusions, analyst models, and relative valuation multiples.

Realty Income's 2025 Milestones Set New Bar

Realty Income's proxy statement paints a picture of operational resilience, with net income per share at $1.17 and total shareholder return of 12.2%, outpacing the FTSE Nareit Equity REITs Index. The company launched a $1.5 billion open-end perpetual life fund and committed $800 million to preferred equity in CityCenter Las Vegas with Blackstone, showcasing capital diversification.

These moves contrast with Healthpeak Properties' trajectory. As a healthcare-centric REIT, Healthpeak focuses on life science, medical office, and post-acute care properties, sectors sensitive to interest rates, occupancy trends, and reimbursement policies. The peer exclusion may reflect Realty Income's shift toward broader net lease strategies, leaving Healthpeak to navigate healthcare-specific headwinds.

Market participants see this as a signal for Healthpeak Properties stock. With fixed charge coverage at 4.7x and $4.1 billion in liquidity for Realty Income, the proxy indirectly benchmarks what robust balance sheets look like, prompting questions on Healthpeak's financing costs and asset values in a high-rate environment.

Healthcare REIT Dynamics Under the Microscope

Healthpeak Properties operates in a niche where occupancy, refinancing risk, and asset values are paramount. The sector faces pressures from elevated financing costs, with medical office and life science properties requiring long-term leases to resilient tenants like hospitals and biotech firms. Peer exclusions like this one spotlight these vulnerabilities.

Realty Income's governance highlights—a fully independent board and annual say-on-pay—set a standard that healthcare REITs must match. For Healthpeak, investors will watch how its portfolio weathers economic cycles, particularly with aging demographics driving demand for post-acute care but regulatory changes impacting reimbursements.

US investors benefit from REIT structures offering high yields and inflation hedges. Healthpeak's focus on essential healthcare real estate positions it for steady income, but the peer shift underscores the need for disciplined underwriting akin to Realty Income's model.

Why US Investors Should Track Healthpeak Now

For American portfolios, Healthpeak Properties stock represents exposure to healthcare real estate, a defensive play amid volatility in cyclicals. With US healthcare spending projected to grow, properties leased to mission-critical operators offer stability. The Realty Income proxy indirectly validates sector outperformance potential when execution aligns with benchmarks.

Domestic investors hold REITs for diversification, with Healthpeak's NYSE listing facilitating easy access via 401(k)s and IRAs. Current triggers like peer realignments prompt reviews of relative valuations, dividend sustainability, and growth pipelines. Monitoring occupancy trends and cap rates remains key for long-term positioning.

This moment matters as Federal Reserve policies influence borrowing costs, directly affecting REIT NAVs. US stakeholders prioritizing income generation find Healthpeak's specialized focus compelling, especially versus broader peers diversifying away from healthcare.

Strategic Implications of Peer Exclusion

Peer group changes influence more than compensation; they shape analyst coverage and index weightings. Healthpeak Properties' removal may lead to recalibrated comps, potentially pressuring multiples if healthcare REITs underperform diversified plays. Realty Income's 15-year AFFO growth streak sets a high bar.

Healthpeak must emphasize its strengths: deep tenant relationships in life sciences and medical offices, where innovation drives leasing demand. Strategic acquisitions or dispositions could counterbalance the exclusion narrative, reinforcing portfolio quality to investors.

Broader REIT market trends favor operators with strong liquidity and coverage ratios, metrics Realty Income flaunts. Healthpeak investors should prioritize updates on debt maturities and equity raises to gauge resilience.

Risks and Open Questions Ahead

Key risks for Healthpeak Properties stock include interest rate persistence, eroding asset values and raising refinancing hurdles. Healthcare-specific challenges like tenant credit quality in biotech and regulatory shifts in Medicare add layers of uncertainty.

Open questions center on portfolio optimization post any historical mergers, with investors seeking clarity on occupancy stabilization and yield accretion from new deals. Competitive dynamics, as evidenced by peer exclusions, could widen valuation gaps if execution lags.

Macro factors like inflation and recession risks test REIT durability. US investors must weigh Healthpeak's yield appeal against potential dividend pressures in a rising rate backdrop.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.